279. 巨大静脈奇形（頚部口腔咽頭びまん性病変） Disease details / Clinical trials / Drug dev / DR info

Alpelisib
   Murdoch Childrens Research Institute
      2024   Phase 2   NCT05983159   Australia
Apixaban
   Oslo University Hospital
      2025   Phase 2   NCT06729034   Norway
Bleomycin + fibrovein
   Oslo University Hospital
      2011   Phase 4   NCT01347294   Norway
Bleomycin baxter
   Department of Radiology, Oslo University Hospital, Norway
      2011   Phase 4   EUCTR2011-001455-37-NO   Norway
Dehydrated alcohol (absolute alcohol) BP FOR injection
   ORFAGEN
      2009   Phase 2   EUCTR2009-011276-29-FR   France
Direct puncture repair / ethanol
   Al-Azhar University
      2018   -   NCT05586919   Egypt
Direct puncture repair / polidocanol
   Al-Azhar University
      2018   -   NCT05586919   Egypt
Enalapril
   Oslo University Hospital
      2025   Phase 2   NCT06788314   Norway
Ethanol
   Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital
      2023   Phase 0   ChiCTR2300071751   China
   Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
      2015   Phase 1 study   ChiCTR-OIB-15007455   China
   Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
      2025   -   ChiCTR2500102907   China
Ethanol 96% GEL
   Orfagen
      2007   Phase 2   NCT00462462   France;United States
Ethanol 98% solution
   Orfagen
      2007   Phase 2   NCT00462462   France;United States
Ethanol BP
   ORFAGEN
      2009   Phase 2   EUCTR2009-011276-29-FR   France
Ethanol GEL
   ORFAGEN
      2009   Phase 2   EUCTR2009-011276-29-FR   France
Ethanol-amine oleate sclerotherapy injection
   Suez Canal University
      2019   -   NCT04930952   Egypt
Ethanolamine oleate
   Danjo Atsushi
      2009   Phase 2   JPRN-jRCTs071180067   -
   Nomura Tadashi
      2021   Phase 3   JPRN-jRCT2051200046   -
Fibrin
   The First Affiliated Hospital of Sun Yat-Sen University
      2022   Phase 2   ChiCTR2100053242   China
Fibrovein
   Department of Radiology, Oslo University Hospital, Norway
      2011   Phase 4   EUCTR2011-001455-37-NO   Norway
L0122
   ORFAGEN
      2009   Phase 2   EUCTR2009-011276-29-FR   France
Mirdametinib
   Murdoch Childrens Research Institute
      2024   Phase 2   NCT05983159   Australia
Polidocanol
   Mori Hiroki
      2024   Phase 2   JPRN-jRCTs031230604   Japan;Non
   Uka Mayu
      2021   -   JPRN-jRCTs061200036   -
Qtorin 3.9% rapamycin anhydrous GEL
   Palvella Therapeutics, Inc.
      2024   Phase 2   NCT06653842   United States
Rapamycin
   Peking Union Medical College Hospital
      2018   Phase 4   NCT03767660   China
Sirolimus
   Children's Hospital Medical Center, Cincinnati
      2009   Phase 2   NCT00975819   United States
   Gifu University Hospital
      2020   Phase 3   JPRN-UMIN000038973   Japan
   Medical University of South Carolina
      2022   Phase 2   NCT04861064   United States
   Shanghai Ninth People's Hospital
      2021   Phase 0   ChiCTR2100052762   China
Trametinib tablet
   Stanford University
      2020   Phase 2   NCT04258046   United States